VivoSeq
Other

Gulf War Illness

0

Pipeline Programs

4

Active Trials

0

Companies Involved

Gulf War Illness is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

16/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

77/100

Attrition Rate

15/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

20

clinical trials

Completed10 · 50%
Recruiting4 · 20%
Terminated3 · 15%
Unknown status3 · 15%

Trial Activity

20 trials

Clinical Evaluation of Montelukast in Veterans With Gulf War Illness
Recruiting··Phase 1·NCT05992311·80 enrolled
Study of Bacopa in Gulf War Illness Patients
Recruiting·NNova Southeastern University·Phase 2·NCT04927338·170 enrolled
Trial of Naltrexone and Dextromethorphan for Gulf War Illness
Completed··Phase 2·NCT02206490·60 enrolled
Ketamine in Veterans With Gulf War Illness
Terminated··Phase 1·NCT04712071·1 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)